Inspection Record

Pillar5 Pharma Inc. — Health Canada Inspection Findings

Health CanadaInspected 2025-12-02 17 findingsOther quality systemDeviation, CAPA, and investigationEquipment and facilityCleaning validationComputer system validationQuality unit oversightRegulatory reporting and change controlAseptic processing and sterility assuranceLaboratory and QC controls

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate.

2Other quality system

The company's monitoring of water testing was inadequate.

3Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

4Other quality system

The assessment to release finished products was inadequate.

5Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate.

6Other quality system

The written clothing standards for each environmental grade were inadequate.

7Cleaning validation

The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.

8Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

9Quality unit oversight

Critical processes and procedures were not evaluated on a regular basis. The annual product quality review procedure was inadequate.

10Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

11Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

12Other quality system

The availability or the content of the authentic certificate of analysis was inadequate.

13Aseptic processing and sterility assurance

The operators'aseptic practices were inadequate to maintain sterility. The company did not adequately protect sterilized material to prevent re-contamination after sterilization.

14Laboratory and QC controls

The creation, maintenance, processing, and/or review of laboratory data was inadequate. The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

15Aseptic processing and sterility assurance

The sampling procedure was inadequate for microbiological monitoring in processing areas or aseptic areas. The company did not set appropriate alert and action limits for the results of particulate and microbiological monitoring.

16Other quality system

The recorded information or details were inadequate.

17Aseptic processing and sterility assurance

The company did not adequately demonstrate that air-flow patterns did not pose a risk of contamination. The process was inadequate for the environmental classification of aseptic or clean areas.

About this record

Extracted automatically from the document of the Health Canada inspection on 2025-12-02. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Pillar5 Pharma Inc. company profile — full history Health Canada documents, 2025 Go to Findings search